Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-25-000016

Director bought 27,500 shares at an average $0.92 ($25,241)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-29 Purchase : show line 1 in the form +15,600 $0.92 $14,375 270,012 I
2025-07-30 Purchase : show line 2 in the form +11,900 $0.91 $10,866 281,912 I
Open-market purchases · 27,500 sh · avg $0.92 · $25,241
Loading xslF345X05/primary_doc.xml…